Abstract
DNA is a complex macromolecule with immunological properties that depend on base sequence. Although mammalian DNA is immunologically inert, DNA from bacteria has potent immunostimulatory properties that result from short sequence motifs called CpG motifs or immunostimulatory sequences (ISS). These motifs, which have the general structure of two 5′ purines, an unmethylated CpG motif, and two 3′ pyrimidines, occur much more commonly in bacterial DNA than mammalian DNA because of two main factors: CpG suppression and the frequent methylation of cytosine in this position in mammalian DNA (1). As a result, bacterial DNA displays (in code-like fashion) sequences emblematic of foreignness. This code allows DNA to function as a danger signal in the induction of innate immunity (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pisetsky, D. S. (1996) Immune activation by bacterial DNA: a new genetic code. Immunity 5, 303–310.
Matzinger, P. (1994) Tolerance, danger, and the extended family. Ann. Rev. Immunol. 12, 991–1045.
Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Katoka, T., et al. (1992) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36, 983–997.
Klinman, D. M., Yi, A-K., Beaucage, S. L., Conover, J., and Krieg, A. M. (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA 93, 2879–2883.
Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Hacker, H., Heeg, K., et al. (1997) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur. J. Immunol. 27, 1671–1679.
Krieg, A. M., Yi, A., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 345–349.
Stein, C. A., Subasinghe, C., Shinozuka, K., and Cohen, J. S. (1988) Physio-chemical properties of phosphorothioate oligodeoxynucleotides. Nucl. Acids Res. 16, 3209–3221.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S., and Lipsky, P. E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119–1129.
Montieth, D. K., Henry, S. P., Howard, R. B., Flournoy, S., Levin, A. A., Bennett, C. F., et al. (1997) Immune stimulation-a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anti-Cancer Drug Design 12, 421–432.
Vogel, F. R. and Sarver, N. (1995) Nucleic acid vaccines. Clin. Microbiol. Rev. 8, 406–410.
Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555–1560.
Leclerc, C., Deriaud, E., Rojas, M., and Whalen, R. G. (1997) The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell. Immunol. 179, 97–106.
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M-D., et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352–354.
Mor, G., Klinman, D. M., Shapiro, S., Hagiwara, E., Sedegah, M., Norman, J. A., et al. (1995) Complexity of the cytokine and antibody response elicited by immunizing mice with Plasodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155, 2039–2046.
Feltquate, D. M., Heaney, S., Webster, R. G., and Robinson H. L. (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278–2284.
Hsieh, C. S., Macatonia, S. E., O’ Garra, A., and Murphy, K. M. (1995) T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181, 713–721.
Mashiba, H., Matsunaga, K., Tomoda, H., Furusawa, M., Jimi, S., and Tokunaga, T. (1988) In vitro augmentation of natural killer activity of peripheral blood cells from cancer patients by a DNA fraction from Mycobacterium bovis BCG. Japan. J. Med. Sci. Biol. 41, 197–202.
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., and Kreig, A. M. (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870–876.
Hsu, C-H., Chua, K-Y., Tao, M-H., Lai, Y-L., Wu, H-D., Huang S-K., et al. (1996) Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med. 2, 540–544.
Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., et al. (1996) Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2, 899–905.
Kimura, Y., Sonehara, K., Kuramoto, E., Makino, T., Yamamoto, S., Yamamoto, T., et al. (1994) Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116, 991–994.
Pearson, A. M., Rich, A., and Krieger, M. (1993) Polynucleotide binding to mac-rophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J. Biol. Chem. 268, 3546–3554.
Lipford, G. B., Sparwasser, T., Bauer, M., Zimmermann, S., Koch, E-S., Heeg, K., etal. (1997) Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27, 3420–3426.
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., et al. (1998) CpG oligonucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160, 3627–3630.
Weiner, G. J., Liu, H-M., Wooldridge, J. E., Dahle, C. E., and Kreig, A. M. (1997) Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA. 94, 10,833–10,837.
Sun, S., Kishimoto, H., and Sprent, J. (1998) DNA as an adjuvant: capacity of insect DNA and Synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187, 1145–1150.
Mor, G., Single, M., Steinberg, D. A., Hoffman, S. L., Okuda, K., and Klinman, D. (1997) Do DNA vaccines induce autoimmune disease? Human Gene Therapy 8, 293–300.
Gilkeson, G. S., Ruiz, P., Howell, D., Lefkowith, J. B., and Pisetsky, D. S. (1993) Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin. Immunol. Immunopath. 68, 283–292.
D’Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., et al. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387–1398.
Halpern, M. D., Kurlander, R. J., and Pisetsky, D. S. (1996) Bacterial DNA induces murine interferon gamma production by stimulation of interleukin-12 and tumor necrosis factor alpha. Cell. Immunol. 167, 72–78.
Wicks, I. P., Howell, M. L., Hancock, T., Kohsaka, H., Olee, T., and Carson, D. A. (1995) Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. Human Gene Therapy 6, 317–323.
Sparwasser, T., Miethke, T., Lipford, G., Borschert, K., Hacker, H., Heeg, K., et al. (1997) Bacterial DNA causes septic shock. Nature 386, 336–337.
Mouthon, M-A., Mitjavila, M-T., Marquet, J., Vainchenker, W., and Wendling, F. (1994) Erroneous results of 3H-thymidine incorporation are related to position of thymidine residues in oligodeoxynucleotides. Exp. Hematology. 22, 384–387.
Manickan, E., Yu, Z., and Rouse, B. T. (1997) DNA Immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Invest. 100, 2371–2375.
Bot, A., Bot, S., Garcia-Sastre, A., and Bona, C. (1996) DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Viral Immunol. 9, 207–210.
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., et al. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2, 893–898.
Hoffman, S. L., Doolan, D. L., Sedegah, M., Gramzinski, R., Wang, H., Gowda, K., et al. (1995) Nucleic acid malaria vaccines. Ann. NY Acad. Sci. 772, 88–94.
Xu, D. and Liew, F. Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L.major. Immunology 84, 173–176.
Slater, J. E., Perry, J. E., Zhang, Y. J., Arthur-Smith, A., and Colberg-Poley, A. (1997) A DNA vaccine inhibits IgE responses to the latex allergen Hev b 5 in mice. J. Allergy Clin. Immunol. 99, S504.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Neujahr, D.C., Pisetsky, D.S. (2000). DNA As an Adjuvant. In: O’Hagan, D.T. (eds) Vaccine Adjuvants. Methods in Molecular Medicine™, vol 42. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-083-7:299
Download citation
DOI: https://doi.org/10.1385/1-59259-083-7:299
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-735-9
Online ISBN: 978-1-59259-083-4
eBook Packages: Springer Protocols